We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA will now allow certain devices to carry stand-alone symbols on labels, in an effort to harmonize international standards used in medical device labeling. Read More
If the FDA conducts a benefit-risk assessment and finds the device has a high benefit to patients and the compliance issue causes little risk, it may decide to work with a company informally, rather than taking an official enforcement action. Read More
Indian regulators have decided to abandon a proposed law that would have amended parts of India’s Drugs and Cosmetic Act of 1940, to pursue more extensive revisions to create a separate device regulation. Read More